Treatment for Brain Metastases from EGFR Mutations NSCLC Patients: How Should We Choose in Clinical Practice?
Brain metastasis of epidermal growth factor receptor (EGFR) sensitive mutations is a hot and difficult point in targeted era of non-small cell lung cancer (NSCLC) treatment, meanwhile it is also the central issue of controversy in the field of lung cancer treatment. Different results of different st...
| Published in: | Chinese Journal of Lung Cancer |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Chinese |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-08-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.29 |
